Natus Medical Incorporated (BABY - FusionIQ Master Technical Score - 97) a medical device company that develops, manufactures, and markets screening products to identify and monitor common medical disorders that may occur between conception to a baby's first birthday scored a new FusionIQ Short Squeeze on Friday.  We love stocks that act strong in a weak tape and BABY shares certainly fit the bill.  With close to 13.00% of its float short and a point and figure target of $ 33.50 and a new FusionIQ BUY signal BABY offers excellent long side return potential.